Tina Mayer

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Matteo Palmeri, Janice M. Mehnert, Ann W. Silk et al. · ESMO Open · 2021 · 353 citations · Full text

Medicine, Immunology, Oncology +17

Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma

Anshuman Panda, Aguirre A. de Cubas, Mark N. Stein et al. · JCI Insight · 2018 · 179 citations · Full text

Medicine, Cancer Biology, Oncology +17

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Mark N. Stein, Joseph R. Bertino, Howard L. Kaufman et al. · Clinical Cancer Research · 2017 · 155 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

Holger Hebart, Lena Klingspor, Thomas Klingebiel et al. · Bone Marrow Transplantation · 2008 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +3